Vaishali Pharma Ltd
Vaishali Pharma Ltd Live Price Chart
Performance
| Previous Close | ₹ 8.33 |
| High | ₹ 8.46 |
| Volume | 58628 |
| 52W Range | ₹ - ₹ |
| Open | ₹ 8.33 |
| Low | ₹ 8.2 |
| Market Cap | ₹ 101.24 Cr |
Vaishali Pharma Ltd Technicals
| 20 Day | ₹ 0.000 |
| 50 Day | ₹ 0.000 |
| 100 Day | ₹ 0.000 |
| 200 Day | ₹ 0.000 |
| 20 Day | ₹ 0.000 |
| 50 Day | ₹ 0.000 |
| 100 Day | ₹ 0.000 |
| 200 Day | ₹ 0.000 |
Vaishali Pharma Ltd Fundamentals
| ROCE | 8.363 |
| P/E Ratio | 25.180 |
| P/B Ratio | 1.570 |
| Industry P/E | 1.570 |
| Debt to Equity | 51.431 |
| ROE | 5.844 |
| EPS | 0.330 |
| Dividend Yield | 0.000 |
| Book Value | 5.288 |
| Face Value | 2.000 |
Vaishali Pharma Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 | Y202203 | Y202103 |
|---|---|---|---|---|---|
| Total Revenue | 102.231 | 88.3133 | 71.8915 | 77.6089 | 55.5829915 |
| Total Expenses | 101.0052 | 87.3872 | 63.0453 | 71.8805 | 54.1784676 |
| Profit After Tax | 0.8174 | 0.7189 | 6.6036 | 4.0237 | 1.0462567 |
Vaishali Pharma Ltd Shareholding Pattern
| Promoter Holdings | 30.545 % |
| FIIs | 0.000 % |
| DIIs | 0.000 % |
| MutualFund | 0.000 % |
| Retail | 60.696 % |
| Others - | 8.760 % |
About Vaishali Pharma Ltd
Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name 'Vaishali Pharma Private Limited' on 25th, April 2008. On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz. M/s. Vaishali Pharmachem through Business Assignment agreement. Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited. Subsequently, the Company converted into a Public Limited Company and the name was changed to Vaishali Pharma Limited on 21st, June 2017. Atul Vasani and Jagruti Vasani are the Promoters of the Company. Vaishali Pharma is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal & nutraceutical products. The Company is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For the export markets, the Company gets the formulations whose facilities are approved and certified by respective countries for developing the products. The Company has over 250 + formulation brands marketed in multiple countries; of which dossier is in CTD format along with its respective bioequivalence. The Company built a robust pipeline of around 250 Dossiers. The Company's synergistic collaboration with WHO-GMP manufacturing facilities is backed by an ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 44.01 +0.88 (+2.04%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 514.25 -2.8 (-0.54%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 7,106.50 -29.5 (-0.41%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 588.10 +28 (+5%) |
| Abbott India Ltd Pharmaceuticals | ₹ 26,175.00 -175 (-0.66%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,423.50 +3.5 (+0.25%) |
FAQs on Vaishali Pharma Ltd
1. Can I buy Vaishali Pharma Ltd from PL Capital? ›
2. Does Vaishali Pharma Ltd pay dividends? ›
3. What is the current share price of Vaishali Pharma Ltd ? ›
4. What is the 52-week high and low of Vaishali Pharma Ltd ? ›
Start SIP in Vaishali Pharma Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
